Long-term Impact Evaluation of a Worksite-based Lifestyle Intervention to Reduce Cardiovascular Risk in Office Workers (TANSNIP-PESA)
Sponsor: Amsterdam UMC, location VUmc
A NA clinical study on Atherosclerosis, this trial is completed. The trial is conducted by Amsterdam UMC, location VUmc and has accumulated 10 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2022 — Jul 2024 [monthly]
Completed NA
-
May 2021 — May 2022 [monthly]
Completed NA
-
Mar 2021 — May 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 5 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting NA
-
Jan 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Enrolling By Invitation → Active Not Recruiting
-
Jun 2018 — Jan 2020 [monthly]
Enrolling By Invitation NA
-
Feb 2017 — Jun 2018 [monthly]
Enrolling By Invitation NA
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation NA
First recorded
May 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Amsterdam UMC, location VUmc
- Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
- Icahn School of Medicine at Mount Sinai
- Instituto de Salud Carlos III
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.